Oral Biologics & Biosimilars Market Revenue, Trends, Market Share Analysis, and Forecast to 2030
The Oral Biologics & Biosimilars Market size is expected to reach USD 88.12 Billion in 2030 and register a revenue CAGR of 21.3% over the forecast period, according to the latest report by Reports and Data. Rapid market revenue growth of biosimilars is due to various factors such as growing geriatric population, increasing incidence of chronic diseases, and shortened regulatory...
0 Σχόλια 0 Μοιράστηκε 31 Views